Ligand profile
H5V
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01981 — Chaperone protein dnaK
Identifiers
Database identifiers and provenance.
- Ligand ID
H5V- PDB
6do2- UniProt (similar protein)
P11021- Target protein
- KP13_01981
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 126.7
- −1 ≤ LogP ≤ 5 -0.98
- MW ≤ 500 Da 280.3
- LogP ≤ 5 -0.98
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 126.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@]1([C@@H]([C@H](O[C@H]1n2ccc3c2ncnc3N)CO)O)OC[C@]1([C@@H]([C@H](O[C@H]1n2ccc3c2ncnc3N)CO)O)O
InChI=1S/C12H16N4O4/c1-12(19)8(18)7(4-17)20-11(12)16-3-2-6-9(13)14-5-15-10(6)16/h2-3,5,7-8,11,17-19H,4H2,1H3,(H2,13,14,15)/t7-,8-,11-,12-/m1/s1InChI=1S/C12H16N4O4/c1-12(19)8(18)7(4-17)20-11(12)16-3-2-6-9(13)14-5-15-10(6)16/h2-3,5,7-8,11,17-19H,4H2,1H3,(H2,13,14,15)/t7-,8-,11-,12-/m1/s1
IRZRJANZDIOOIF-GAJNKVMBSA-NIRZRJANZDIOOIF-GAJNKVMBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00012
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand H5V →
- PDB RCSB structure 6do2 →
- UniProt UniProt P11021 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “H5V”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01981.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).